End Button Tenodesis in Failed Developmental Dysplasia of the Hip Surgery

October 29, 2022 updated by: Ahmed Obeid Abd Allah, Al-Azhar University

The Role of End Button Tenodesis in the Management of Failed Developmental Dysplasia of the Hip Surgery

Adequate growth and development of the hip depends on two main factors: concentric positioning of femoral head into the acetabular cavity and adequate balance in growth between tri-radiate and acetabular cartilage. Any alteration in these two conditions leads to a hip dysplasia & dislocation

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

3

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: ahmed khashaba, MD
  • Phone Number: 01023233949

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

1 year to 10 years (Child)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

The patients will be examined for:

Length of both lower limbs in relation to each other. Length of both lower limbs according to patient age. Presence of hump related to the outer surface of the hip Presence of pain, abnormal gait, Trendlenburg test Radiographic evaluation (antero posterior and frog pelvis views)

An addition to the steps of the open reduction, the following were done:

  1. Trans articular suturing
  2. End button tenodesis

Description

Inclusion Criteria:

- Patient with Developmental dysplasia of the hip (DDH) with :

  • Age: up to 9 years old.
  • Recurrent DDH .
  • Failed open reduction through medial approach in the management of DDH.
  • Traumatic hip dislocation .

Exclusion Criteria:

  • • Paralytic hip dislocation .

    • Post septic hip dislocation.
    • Refusal to participate in this study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Tenodesis by end button
open reduction of the dislocated hip and stabilization by end button
Procedure: Tenodesis by end button
open reduction of the dislocated hip and stabilization by end button

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
modified Harris Hip Score
Time Frame: 6 months
score for function of the hip
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Al-Azhar University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

November 29, 2022

Primary Completion (Anticipated)

November 29, 2023

Study Completion (Anticipated)

November 29, 2023

Study Registration Dates

First Submitted

October 29, 2022

First Submitted That Met QC Criteria

October 29, 2022

First Posted (Actual)

November 3, 2022

Study Record Updates

Last Update Posted (Actual)

November 3, 2022

Last Update Submitted That Met QC Criteria

October 29, 2022

Last Verified

October 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • EBT

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Orthopedic Disorder

Clinical Trials on Tenodesis by end button

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Australia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe